CVE-2017-0144

CVE-2017-0144 is a remote code execution flaw in the SMBv1 server component of Microsoft Windows, commonly known as EternalBlue, and one of the SMB flaws fixed by Microsoft in the March 2017 MS17-010 bulletin. An attacker who can reach the SMB service over the network sends specially crafted packets that trigger memory corruption in the SMBv1 implementation, gaining the ability to execute arbitrary code on the target without user interaction. Successful exploitation yields full system compromise and has been heavily weaponized for wormable spread and ransomware delivery, notably via the leaked NSA exploit and in the WannaCry/NotPetya-era outbreaks, and the flaw has repeatedly been bundled into botnets and ransomware tooling since. Anyone running unpatched Windows Vista SP2 through Windows 10 1607 / Windows Server 2016 with SMBv1 enabled is affected, as are Siemens medical and laboratory devices (ACUSON ultrasound, syngo SC2000, Tissue Preparation System, VERSANT kPCR systems) whose firmware depends on SMBv1. Exploitation is actively ongoing: the flaw is in CISA's Known Exploited Vulnerabilities catalog (added 2022-02-10) with known ransomware use, carries a 99.2% EPSS exploitation probability (100th percentile), and multiple public exploits and PoCs are available.

What to do: Apply the Microsoft MS17-010 (March 2017) security updates on every listed Windows version and the corresponding Siemens firmware updates for ACUSON, syngo SC2000, Tissue Preparation System, and VERSANT kPCR devices, per CISA's required action to apply vendor updates. Where patching is not yet possible, disable SMBv1 or block inbound TCP 445 (and UDP 137/138) at network boundaries and isolate legacy/medical systems from the internet. Sweep exposed and legacy hosts for compromise indicators, including DOUBLEPULSAR implants delivered over SMB, as public tooling for detecting and neutralizing this implant is available.